Indeed, oral gavage of GMI demonstrated remarkable inhibition of tumor growth in lung pemetrexed-resistant CD133+ A549/A400 tumor-bearing mice and significantly decreased CD133 expression in the tumor, indicating good tumor-penetrating capabilities. This evidence concerns the gene PROM1 and neoplasm.